Kehua Bioengineering Co., Ltd.

Announcement on the Registration Certificate for Medical Devices Obtained by the Product

Announcement on the Product Obtaining Medical Device Registration Certificate

Legal Opinion from Beijing Jindu (Guangzhou) Law Firm Regarding the 2025 Annual Shareholders' Meeting of Shanghai Kehua Bio-engineering Co., Ltd.

Announcement of the 2025 Annual Shareholders' Meeting Resolutions

Announcement on the obtaining of medical device registration certificate for products

Announcement of the resolution of the 21st meeting of the 10th board of directors

First quarter report of 2026

Announcement on the obtaining of medical device registration certificate for products

2025 annual audit report

2025 Board of Directors Work Report

Shareholder Dividend Return Plan for the Next Three Years (2026-2028)

Announcement on Confirming the Compensation for Directors and Senior Management for the Year 2025 and the Compensation Plan for 2026

Announcement on the Purchase of Directors and Officers Liability Insurance

2025 Annual Report on Independent Directors (Zheng Chuanfang)

2025 Annual Report of Independent Directors (Shan Wenhua)

2025 Annual Debriefing Report of Independent Directors (Zhang Zhenxi)

Announcement on holding the 2025 annual results briefing

Internal Control Audit Report

This report presents the results of an audit of the internal financial controls of Shanghai Kehua Bio-engineering Co., Ltd. for the year ended December 31, 2025. The audit was conducted by RSM China Certified Public Accountants. The report concludes that the company maintained effective internal financial controls in all material respects.

2025 internal control self-evaluation report

Remuneration Management System for Directors and Senior Management (Revised in April 2026)

Announcement on the provision for asset impairment in 2025

CITIC Securities Co., Ltd.'s verification opinions on the postponement of some fundraising projects of Shanghai Kehua Bioengineering Co., Ltd

Announcement on the postponement of some fundraising projects

Feasibility analysis report on foreign exchange hedging business

Announcement on the foreign exchange hedging business carried out by the company and its subsidiaries

Notice of the 2025 Annual Shareholders' Meeting

Announcement of Resolutions from the Twentieth Meeting of the Tenth Board of Directors

Announcement on the intention not to distribute profits in 2025

Special report on the deposit and use of raised funds in 2025

CITIC Securities Co., Ltd. Special Verification Report on the Deposit and Use of Raised Funds of Shanghai Kehua Bioengineering Co., Ltd. in 2025

Assurance Report on the Deposit and Use of Raised Funds

This report provides assurance on Shanghai Kehua Bio-engineering Co., Ltd.'s 2025 annual report regarding the deposit and use of raised funds. The auditors conclude that the company's report accurately reflects its actual fund deposit, management, and usage in accordance with regulations. No material issues were found regarding the use or disclosure of raised funds.

Special Audit Report on the Deduction of Operating Income for the Year 2025